Pharmacological inactivation or genetic invalidation of CKMT1 abrogates ATP production and mitochondrial respiration, decreases viability of EVI1 AML, and prolongs the survival of the mice engrafted with high EVI1-expressing AML cells compared to xenograft with low EVI1-expressing AML cells. The gene discussed is RUNX1; the disease is acute myeloid leukemia.